Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 5, 2005, Pages 361-367

  Rizzo, Manfredi ^a   Barbagallo, Carlo M ^a   Noto, Davide ^a   Pace, Antonio ^a   Cefalú, Angelo B ^a   Pernice, Vincenzo ^b   Pinto, Vito ^b   Rubino, Antonino ^b   Pieri, Daniele ^b   Traina, Marcello ^b   Frasheri, Arian ^b   Notarbartolo, Alberto ^a   Averna, Maurizio R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Villa Maria Eleonora Hospital   (Italy)

Author keywords

Adverse events; Coronary angiography; Coronary angioplasty; Follow up; Predictors

Indexed keywords

EID: 27644597037     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.02.004     Document Type: Article

References (36)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3373-421.
2. Averna MR, Barbagallo CM, Ocello S, Doria O, Davi G, Scafidi V, et al. Lp(a) levels in patients undergoing aortocoronary bypass surgery. Eur Heart J 1992;13:1405-9.
3. Poyen V, Silvestri M, Labrunie P, Valeix B. Indications of coronary angioplasty and stenting in 2003: what is left to surgery? J Cardiovasc Surg 2003;44:307-12.
4. Gunn J, Crossman D, Grech ED, Cumberland D. New developments in percutaneous coronary intervention. BMJ 2003;27:150-3.
5. Maron DJ. Percutaneous coronary intervention versus medical therapy for coronary heart disease. Curr Atheroscler Rep 2000;2:290-6.
6. Indolfi C, Mongiardo A, Curcio A, Torella D. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. Trends Cardiovasc Med 2003;13:142-8.
7. Levine GN, Kern MJ, Berger PB, Brown DL, Klein LW, Kereiakes DJ, et al. American Heart Association Diagnostic and Interventional Catheterization Committee and Council on Clinical Cardiology. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139:123-36.
8. van Domburg RT, Foley DP, de Feyter PJ, van der Giessen W, van den Brand MJ, Serruys PW. Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J 2001;22:934-41.
9. Padilla AJ, Vega RA, Llado IJ, Conde JG. Predictors of adverse events after percutaneous transluminal coronary angioplasty in a group of Hispanic patients. P R Health Sci J 2001;20:5-11.
10. Sheiban I, Leonardo F, Rosano GM, Pagnotta P, Marsico F, Montorfano M, et al. Predictors of long-term clinical outcome in patients undergoing multiple vessel stenting for coronary artery disease. Ital Heart J 2000;1:480-6.
11. Briguori C, Nishida T, Adamian M, Di Mario C, Moses J, Colombo A. Multivessel coronary stenting: predictors of early and late outcome. Ital Heart J 2000;1:420-5.
12. Espinola-Klein C, Rupprecht HJ, Erbel R, Nafe B, Brennecke R, Meyer J. Predictors of adverse outcome 10 years after coronary angioplasty. J Invasive Cardiol 1999;11:722-8.
13. Taddei CF, Weintraub WS, Douglas Jr JS, Ghazzal Z, Mahoney E, Thompson T, et al. Influence of age on outcome after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;84:245-51.
14. Guiteras-Val P, Varas-Lorenzo C, Garcia-Picart J, Marti-Claramunt V, Auge-Sanpera JM. Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;83:868-74.
15. Halon DA, Merdler A, Flugelman MY, Shifroni G, Khader N, Shiran A, et al. Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center. Am J Cardiol 1998;82:547-53.
16. Harrell L, Schunkert H, Palacios IF. Risk predictors in patients scheduled for percutaneous coronary revascularization. Catheter Cardiovasc Interv 1999;48:253-60.
17. Zellweger MJ, Weinbacher M, Zutter AW, Jeger RV, Mueller-Brand J, Kaiser C, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003;42:41-4.
18. Takagi T, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos V, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation 2002;106:698-702.
19. Olivari Z, Rubartelli P, Piscione F, Ettori F, Fontanelli A, Salemme L, et al. TOAST-GISE Investigators. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol 2003;41:1672-8.
20. Klugherz BD, Meneveau NF, Kolansky DM, Herrmann HC, Schiele F, Matthai Jr WH, et al. Predictors of clinical outcome following percutaneous intervention for in-stent restenosis. Am J Cardiol 2000;85:1427-31.
21. Mercado N, Boersma E, Wijns W, Gersh BJ, Morillo CA, de Valk V, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis. A comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001;38:645-52.
22. Heidland UE, Heintzen MP, Michel CJ, Strauer BE. Risk factors for the development of restenosis following stent implantation of venous bypass grafts. Heart 2001;85:312-7.
23. Suselbeck T, Latsch A, Siri H, Gonska B, Poerner T, Pfleger S, et al. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol 2001;88:243-7.
24. Johansen O, Abdelnoor M, Brekke M, Seljeflot I, Hostmark AT, Arnesen H. Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables. Scand Cardiovasc J 2001;35:86-91.
25. Horne BD, Muhlestein JB, Strobel GG, Carlquist JF, Bair TL, Anderson JL. Intermountain Heart Collaborative (IHC) Study Group. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 2002;44:491-500.
26. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
27. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeldet AW, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984;22:165-74.
28. Warnick GR, Nguyen T, Albers JJ. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem 1985;31:217-22.
29. Pepine CJ, Allen HD, Bashore TM, Brinker JA, Cohn LH, Dillon JC, et al. ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. Circulation 1991;84:2213-47.
30. Robins SJ, Collins D, Wittes JT, Papademetroiu V, Deedwania PC, Schaefer EJ, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 2001;285:1585-91.
31. Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, et al, on behalf of the VA-HIT study group. Insulin resistance and cardiovascular events with low HDL cholesterol. Diabetes Care 2003;26:1513-7.
32. Monraats PS, R.P. Agema W, Jukema JW. Genetic predictive factors in restenosis. Pathol Biol (Paris) 2004;52:186-95.
33. Volzke H, Grimm R, Robinson DM, Wolff B, Schwahn C, Hertwig S, et al. Candidate genetic markers and the risk of restenosis after coronary angioplasty. Clin Sci (Lond) 2004;106:35-42.
34. Zee RY, Hoh J, Cheng S, Reynolds R, Grow MA, Silbergleit A, et al. Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease. Pharmacogenomics J 2002;2:197-201.
35. Kastrati A, Dirschinger J, Schomig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz 2000;25:34-46.
36. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, et al. For the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39.